C
Cemtas Celik Makina Sanayi ve Ticaret AS
IST:CEMTS.E
Cemtas Celik Makina Sanayi ve Ticaret AS
IST:CEMTS.E
Price:
10.3
TRY
-0.68%
Market Closed
Market Cap:
₺5.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cemtas Celik Makina Sanayi ve Ticaret AS
IST:CEMTS.E
|
TR |
|
Asia Allied Infrastructure Holdings Ltd
HKEX:711
|
HK |
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
Income Statement
Earnings Waterfall
Cemtas Celik Makina Sanayi ve Ticaret AS
Cemtas Celik Makina Sanayi ve Ticaret AS
Income Statement
Cemtas Celik Makina Sanayi ve Ticaret AS
Cemtas Celik Makina Sanayi ve Ticaret AS
Currency: TRY
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
3
|
0
|
0
|
0
|
2
|
12
|
23
|
58
|
68
|
72
|
66
|
36
|
32
|
28
|
35
|
41
|
45
|
0
|
0
|
0
|
|
| Revenue |
901
N/A
|
1 074
+19%
|
1 295
+21%
|
1 511
+17%
|
1 989
+32%
|
2 639
+33%
|
3 007
+14%
|
6 477
+115%
|
3 387
-48%
|
3 276
-3%
|
3 617
+10%
|
7 211
+99%
|
5 756
-20%
|
7 999
+39%
|
8 134
+2%
|
7 557
-7%
|
7 041
-7%
|
5 472
-22%
|
5 843
+7%
|
6 271
+7%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(718)
|
(826)
|
(972)
|
(1 069)
|
(1 302)
|
(1 688)
|
(1 955)
|
(5 033)
|
(2 527)
|
(2 554)
|
(2 744)
|
(5 920)
|
(4 640)
|
(6 566)
|
(6 822)
|
(6 459)
|
(6 014)
|
(4 708)
|
(5 014)
|
(5 285)
|
|
| Gross Profit |
183
N/A
|
248
+35%
|
323
+30%
|
442
+37%
|
687
+55%
|
952
+39%
|
1 052
+11%
|
1 444
+37%
|
860
-40%
|
722
-16%
|
873
+21%
|
1 291
+48%
|
1 116
-14%
|
1 433
+28%
|
1 312
-8%
|
1 098
-16%
|
1 027
-6%
|
765
-25%
|
829
+8%
|
987
+19%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(45)
|
(66)
|
(70)
|
(85)
|
(102)
|
(115)
|
(127)
|
(264)
|
(141)
|
(156)
|
(178)
|
(270)
|
(351)
|
(529)
|
(573)
|
(575)
|
(597)
|
(491)
|
(542)
|
(583)
|
|
| Selling, General & Administrative |
(51)
|
(62)
|
(64)
|
(75)
|
(91)
|
(105)
|
(122)
|
(251)
|
(144)
|
(162)
|
(187)
|
(359)
|
(331)
|
(480)
|
(521)
|
(503)
|
(526)
|
(443)
|
(490)
|
(538)
|
|
| Research & Development |
(2)
|
(2)
|
(1)
|
(5)
|
(6)
|
(6)
|
(6)
|
(4)
|
(6)
|
(10)
|
(10)
|
(28)
|
(21)
|
(42)
|
(47)
|
(39)
|
(46)
|
(23)
|
(19)
|
(16)
|
|
| Depreciation & Amortization |
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(8)
|
(4)
|
(4)
|
(4)
|
(14)
|
(15)
|
0
|
0
|
(17)
|
(6)
|
0
|
0
|
(17)
|
|
| Other Operating Expenses |
12
|
2
|
(1)
|
(1)
|
(2)
|
(0)
|
4
|
(1)
|
13
|
20
|
23
|
131
|
17
|
(8)
|
(6)
|
(16)
|
(19)
|
(26)
|
(33)
|
(12)
|
|
| Operating Income |
138
N/A
|
182
+32%
|
254
+39%
|
357
+41%
|
585
+64%
|
837
+43%
|
924
+10%
|
1 180
+28%
|
719
-39%
|
566
-21%
|
695
+23%
|
1 021
+47%
|
766
-25%
|
904
+18%
|
739
-18%
|
523
-29%
|
429
-18%
|
274
-36%
|
287
+5%
|
404
+41%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
57
|
65
|
32
|
145
|
176
|
192
|
271
|
372
|
238
|
388
|
466
|
592
|
573
|
626
|
533
|
621
|
498
|
346
|
333
|
261
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
2
|
(0)
|
(3)
|
(3)
|
0
|
(3)
|
0
|
(0)
|
1
|
2
|
3
|
4
|
7
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
4
|
4
|
5
|
4
|
1
|
1
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(614)
|
(4)
|
(2)
|
(2)
|
(1 169)
|
(999)
|
(1 434)
|
(1 648)
|
(1 101)
|
(958)
|
(606)
|
(506)
|
(447)
|
|
| Pre-Tax Income |
193
N/A
|
246
+28%
|
284
+16%
|
501
+76%
|
760
+52%
|
1 026
+35%
|
1 193
+16%
|
940
-21%
|
954
+1%
|
949
0%
|
1 157
+22%
|
447
-61%
|
341
-24%
|
101
-70%
|
(372)
N/A
|
45
N/A
|
(29)
N/A
|
16
N/A
|
118
+643%
|
225
+90%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
(35)
|
(56)
|
(67)
|
(98)
|
(156)
|
(209)
|
(194)
|
(409)
|
(125)
|
(74)
|
(177)
|
(328)
|
(297)
|
(347)
|
(284)
|
(84)
|
(156)
|
(47)
|
(97)
|
(341)
|
|
| Income from Continuing Operations |
158
|
190
|
218
|
403
|
604
|
817
|
999
|
531
|
829
|
875
|
980
|
119
|
44
|
(246)
|
(656)
|
(39)
|
(185)
|
(32)
|
21
|
(116)
|
|
| Net Income (Common) |
158
N/A
|
190
+20%
|
218
+15%
|
403
+85%
|
604
+50%
|
817
+35%
|
999
+22%
|
531
-47%
|
829
+56%
|
875
+6%
|
980
+12%
|
119
-88%
|
44
-63%
|
(246)
N/A
|
(656)
-166%
|
(39)
+94%
|
(185)
-373%
|
(32)
+83%
|
21
N/A
|
(116)
N/A
|
|
| EPS (Diluted) |
1.57
N/A
|
1.88
+20%
|
2.16
+15%
|
0.81
-63%
|
5.98
+638%
|
8.09
+35%
|
1.99
-75%
|
1.06
-47%
|
1.65
+56%
|
1.75
+6%
|
1.96
+12%
|
0.24
-88%
|
0.09
-63%
|
-0.49
N/A
|
-1.31
-167%
|
-0.08
+94%
|
-0.37
-362%
|
-0.06
+84%
|
0.04
N/A
|
-0.23
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
